FDA

Acticor Biotech Announces the Completion of Enrollment in its GARDEN clinical trial, a COVID-19-induced Acute Respiratory Distress Syndrome Efficacy Study

Show more

SoniVie Receives FDA Breakthrough Device Designation for the TIVUS System for Renal Artery Denervation

Show more